FDA Drug Recalls

Recalls / Class III

Class IIID-0488-2015

Product

Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90

Affected lot / code info
Lot # 956000M, Exp. Aug 2016; UPC 3-6203760090-6

Why it was recalled

Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell

Recalling firm

Firm
Actavis Laboratories, FL, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
4955 Orange Dr, N/A, Davie, Florida 33314-3902

Distribution

Quantity
2,628 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-03-26
FDA classified
2015-04-15
Posted by FDA
2015-04-22
Terminated
2016-12-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0488-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.